<DOC>
	<DOCNO>NCT00873483</DOCNO>
	<brief_summary>Birth Control Patch Study</brief_summary>
	<brief_title>US Ovulation Inhibition Study Obese Women</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Gestodene</mesh_term>
	<mesh_term>Femovan</mesh_term>
	<criteria>Female subject request contraception Age : 18 35 year ( inclusive ) ; smoker must older 30 year time informed consent Normal cervical smear require followup ( cervical smear take screen visit normal result document within previous 6 month ) History regular cyclic menstrual period Willingness use nonhormonal method contraception entire study . Pregnancy lactation ( le 3 menstrual cycle since delivery , abortion , lactation start treatment ) Hypersensitivity ingredient study drug Significant skin reaction transdermal preparation sensitivity surgical/medical tape Any diseases condition compromise function body system could result altered absorption , excessive accumulation , impaired metabolism , alter excretion study drug ( e.g. , know skin disease suspect alteration dermal absorption poor adherence patch psoriasis ) Any disease condition may worsen hormonal treatment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Pregnancy prevention</keyword>
	<keyword>female contraception</keyword>
	<keyword>patch</keyword>
</DOC>